Zachary BurkeAlexander MuirAndreas RauscheckerJames SmithyJennifer N. VegaZachary Burke, Alexander Muir, Andreas Rauschecker, James Smithy, and Jennifer N. Vega received the 2024 National Comprehensive Cancer Network Foundation Young Investigator Awards.
Fox Chase Cancer Center opened its newly expanded Buckingham site, located in Furlong, PA.
The 12th Chuckstrong Tailgate Gala included former Colts quarterback Andrew Luck and raised $1.5 million for research at the Indiana University Melvin and Bren Simon Comprehensive Cancer Center.
Julie BaumanStephanie V. BlankJulie Bauman and Stephanie V. Blank were named chair and vice chair, respectively, of the NRG Oncology Cancer Prevention & Control Committee.
Matt Kalaycio was named chair of the board of directors at the National Comprehensive Cancer Network. Christopher H. Lieu was elected as vice chair, succeeding Kalaycio in the position he has held since 2022.
Nancy Hanley Eriksson and Kevin Conroy received John S. McCain Leadership Awards from Translational Genomics Research Institute (TGen), part of City of Hope, at the institute’s 2024 Founders Dinner, an annual gathering held April 4 in Scottsdale, AZ.Â
A clinic at The Ohio State University Comprehensive Cancer Center—Arthur G. James Cancer Hospital and Richard J. Solove Research Institute and Pelotonia Immuno-Oncology Institute aims to help manage the autoimmune side effects of immunotherapy-based cancer treatment and allow patients to live the fullest life possible both during cancer treatment and long-term as a survivor.
Researchers at NYU Dentistry’s Pain Research Center have been awarded a five-year, $8 million NIH grant to study signaling mechanisms that generate oral cancer pain. The funding is part of the NIH’s Helping to End Addiction Long-term Initiative, which supports the development of safe and effective therapeutics to treat pain in an effort to end the opioid crisis.
The University of Arkansas for Medical Sciences will receive $1 million from the Judd Hill Foundation’s Fund for Excellence in support of the UAMS Northeast Regional Campus and cancer patients in the region.
Albert Bourla, Pfizer’s chairman and CEO, will receive the 2024 the American Association for Cancer Research Outstanding Achievement Award for Service to Cancer Science and Medicine during the AACR Annual Meeting 2024, to be held April 5-10 in San Diego, California.Â
